Lataa...
Clinical Utility of FoundationOne Tissue Molecular Profiling in Men with Metastatic Prostate Cancer
PURPOSE: Targeted inhibitors and immunotherapy have entered the treatment landscape of metastatic prostate cancer. Genomic testing may uncover which patients benefit most from these therapies. We report the clinical utility and benefits of FoundationOne testing in men with advanced prostate cancer....
Tallennettuna:
| Julkaisussa: | Urol Oncol |
|---|---|
| Päätekijät: | , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6823135/ https://ncbi.nlm.nih.gov/pubmed/31327751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2019.06.015 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|